Ozden Rabia Gurses 4
4 · Adverum Biotechnologies, Inc. · Filed Feb 27, 2025
Insider Transaction Report
Form 4
Ozden Rabia Gurses
Chief Medical Officer
Transactions
- Award
Common Stock
2025-02-25+8,125→ 8,125 total - Award
Stock Option (Right to Buy)
2025-02-25+48,750→ 48,750 totalExercise: $4.20Exp: 2035-02-24→ Common Stock (48,750 underlying)
Footnotes (2)
- [F1]Represents shares of Common Stock issuable upon settlement of a restricted stock unit ("RSU") grant that will vest as to one-third (1/3rd) of the total number of shares subject to this award on each anniversary of March 1, 2025 (the "Vesting Commencement Date"), so that all of the shares subject to the RSUs are vested on the third (3rd) annual anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each vesting date.
- [F2]Twenty-five percent (25%) of the total number shares subject to the Option shall vest and become exercisable one year after the Vesting Commencement Date, and one-forty-eighth (1/48th) of the total number of shares subject to the Option shall vest and become exercisable each month thereafter, so that all of the shares subject to the Option are vested and exercisable on the fourth (4th) anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each vesting date.